Sexuality – Lifestyle
Author:
LEADS BIOLABS CO. LTD
Leads Biolabs’ Opamtistomig (LBL-024) Enrolls First ESCC Patient, Exploring Dual PD-L1/4-1BB Mechanism for Superior Survival Benefits in China’s High-Incidence Cancer
March 9, 2026